{"url_path":"/sec/amsf/8-k/2026-06-12/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1018979/0001193125-26-269381-index.html","accession_number":"0001193125-26-269381","cik":"0001018979","ticker":"AMSF","issuer_name":"AMERISAFE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1018979/0001193125-26-269381-index.html","primary_entity_key":"0001018979","primary_entity_name":"AMERISAFE INC"},"word_count":347,"has_tables":true,"body_markdown":"Item 5.07.\n\nSubmission of Matters to a Vote of Security Holders.\n\nThe Company held the 2026 Annual Meeting on June 10, 2026 at the Company’s corporate headquarters in DeRidder, Louisiana. The voting results for each matter submitted to the Company’s shareholders for approval, as described in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 24, 2026 (the “2026 Proxy Statement”), is provided below.\n\nOf the 18,703,771 shares of the Company’s common stock outstanding as of April 16, 2026, the record date for the 2026 Annual Meeting, 17,128,230 shares were represented in person or by proxy at the 2026 Annual Meeting. The inspector of election reported the final vote of the Company’s shareholders as follows:\n\n \n\n \n1.\n\nElection of directors. The following director nominees were elected for terms expiring at the Company’s 2029 annual meeting of shareholders:\n\n \n\nName\n\n  \nVotes For\n \n  \nVotes Withheld\n \n  \nBroker Non-Votes\n \n\nMichael J. Brown\n\n  \n \n15,120,165\n \n  \n \n859,290\n \n  \n \n1,148,775\n \n\nG. Janelle Frost\n\n  \n \n15,651,044\n \n  \n \n328,411\n \n  \n \n1,148,775\n \n\nSean M. Traynor\n\n  \n \n15,660,680\n \n  \n \n318,775\n \n  \n \n1,148,775\n \n\n \n\n \n2.\n\nAdvisory vote to approve the Company’s compensation of its named executive officers. The compensation of the Company’s named executive officers, as disclosed in the 2026 Proxy Statement under “Executive Compensation” and discussed under “Compensation Discussion and Analysis,” was approved on an advisory basis.\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n \n\nBroker Non-Votes\n\n15,834,256\n \n138,678\n \n6,521\n \n1,148,775\n\n \n\n \n3.\n\nRatification of appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026. The appointment of Ernst & Young was ratified.\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n16,694,687\n \n430,980\n \n2,563\n\n \n\n \n4.\n\nApproval of the Officer Exculpation Amendment. The amendment to the Company’s Certificate of Formation to provide for officer exculpation was not approved, as the votes in favor did not exceed the required two-thirds of the Company’s outstanding shares of common stock.\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n \n\nBroker Non-Votes\n\n8,963,682\n \n7,013,076\n \n2,697\n \n1,148,775\n\n \n5.\n\nApproval of the Technical Amendments. The amendment to the Company’s Certificate of Formation to make the Technical Amendments was approved.\n\n \n\nVotes For\n\n \n\nVotes Against\n\n \n\nAbstentions\n\n \n\nBroker Non-Votes\n\n15,937,796\n \n39,198\n \n2,461\n \n1,148,775"}